SI1976562T1 - Vodotopni filmi, ki zajemajo alginate z nizko stopnjo viskoznosti - Google Patents
Vodotopni filmi, ki zajemajo alginate z nizko stopnjo viskoznosti Download PDFInfo
- Publication number
- SI1976562T1 SI1976562T1 SI200632248T SI200632248T SI1976562T1 SI 1976562 T1 SI1976562 T1 SI 1976562T1 SI 200632248 T SI200632248 T SI 200632248T SI 200632248 T SI200632248 T SI 200632248T SI 1976562 T1 SI1976562 T1 SI 1976562T1
- Authority
- SI
- Slovenia
- Prior art keywords
- film
- weight
- active substance
- solution
- forming agent
- Prior art date
Links
- 235000010443 alginic acid Nutrition 0.000 title claims 2
- 229920000615 alginic acid Polymers 0.000 title claims 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical class O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims abstract 12
- 150000001768 cations Chemical class 0.000 claims abstract 12
- 239000000203 mixture Substances 0.000 claims abstract 10
- 238000000034 method Methods 0.000 claims abstract 6
- 239000007864 aqueous solution Substances 0.000 claims abstract 4
- 239000003795 chemical substances by application Substances 0.000 claims 12
- 239000000243 solution Substances 0.000 claims 12
- 239000013543 active substance Substances 0.000 claims 9
- 229940088623 biologically active substance Drugs 0.000 claims 8
- AEMOLEFTQBMNLQ-BZINKQHNSA-N D-Guluronic Acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@@H](O)[C@H]1O AEMOLEFTQBMNLQ-BZINKQHNSA-N 0.000 claims 5
- 238000009472 formulation Methods 0.000 claims 4
- 239000007787 solid Substances 0.000 claims 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 3
- 239000000945 filler Substances 0.000 claims 2
- 239000004014 plasticizer Substances 0.000 claims 2
- 229940072056 alginate Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Addiction (AREA)
- Neurosurgery (AREA)
- Microbiology (AREA)
- Rheumatology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Psychiatry (AREA)
- Mycology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Jellies, Jams, And Syrups (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
- Manufacture Of Macromolecular Shaped Articles (AREA)
Claims (15)
- VODOTOPNI FILMI, KI ZAJEMAJO ALGINATE Z NIZKO STOPNJO VISKOZNOSTI Patentni zahtevki1. Vodotopni film, ki zajema najmanj eno biološko aktivno snov in/ali najmanj eno terapevtsko aktivno snov ter sredstvo za tvorjenje filma, pri čemer je omenjeno sredstvo za tvorjenje filma sestavljeno iz alginatne soli monovalentnega kationa ali mešanice alginatnih soli monovalentnega kationa ter pri čemer ima omenjeno sredstvo za tvorjenje filma guluronat (G) s povprečno vsebnostjo od 50- do 85-odstotnega masnega deleža, manuronat (M) s povprečno vsebnostjo od 15- do 50-odstotnega masnega deleža in povprečno molekulsko maso od 30.000 g/mol do 90.000 g/mol, pri čemer ima njuna 10-odstotna vodna raztopina pri temperaturi 20 °C viskoznost 100-1000 mPas, izmerjeno pri strižni hitrosti 20vrt./min z uporabo viskozimetra znamke Brookfield z vretenom št. 2, pri čemer je omenjeni film mogoče pridobiti s pripravo raztopine omenjenega sredstva za tvorjenje filma, pri čemer raztopina vsebuje tudi najmanj eno biološko aktivno snov in/ali najmanj eno terapevtsko aktivno snov, tako da se raztopino razporedi po trdni površini in omogoči, da se posuši na njej.
- 2. Film v skladu s patentnim zahtevkom 1, pri čemer je monovalentni kation izbran med Na+, K+ in NH4+.
- 3. Film v skladu s patentnim zahtevkom 1 ali 2, pri čemer alginatna sol monovalentnega kationa zajema od 25- do 35-odstotni masni delež β-D manuronata in/ali od 65- do 75-odstotni masni delež α-D guluronata.
- 4. Film v skladu s katerim koli patentnim zahtevkom 1-3, ki zajema plastifikator in/ali polnilo.
- 5. Film v skladu s katerim koli patentnim zahtevkom 1-4, ki ima debelino od 0,1 do 2 mm.
- 6. Film v skladu s katerim koli patentnim zahtevkom 1-5, pri čemer je najmanj ena biološko aktivna snov in/ali najmanj ena terapevtsko aktivna snov raztopljena ali suspendirana v raztopini.
- 7. Film v skladu s katerim koli patentnim zahtevkom od 1 do 6, pri čemer je biološko in/ali terapevtsko aktivna snov prisotna v koncentraciji od 0,000001 -odstotnega masnega deleža do 85-odstotnega masnega deleža skupne mase formulacije filma, po možnosti od 30-odstotnega masnega deleža do 80-odstotnega masnega deleža skupne mase formulacije filma, po možnosti zlasti od 50-odstotnega masnega deleža do 70-odstotnega masnega deleža skupne mase formulacije filma.
- 8. Odmerek, ki zajema formulacijo filma v skladu s patentnim zahtevkom 6 ali 7.
- 9. Metoda za proizvodnjo vodotopnega filma, ki zajema najmanj eno biološko aktivno snov in/ali najmanj eno terapevtsko aktivno snov ter sredstvo za tvorjenje filma, pri čemer je omenjeno sredstvo za tvorjenje filma sestavljeno iz alginatne soli monovalentnega kationa ali mešanice alginatnih soli monovalentnega kationa ter pri čemer ima omenjeno sredstvo za tvorjenje filma guluronat (G) s povprečno vsebnostjo od 50- do 85-odstotnega masnega deleža, manuronat (M) s povprečno vsebnostjo od 15- do 50-odstotnega masnega deleža in povprečno molekulsko maso od 30.000 g/mol do 90.000 g/mol, pri čemer ima njuna 10-odstotna vodna raztopina pri temperaturi 20 °C viskoznost 100-1000 mPas, izmerjeno pri strižni hitrosti 20 vrt./min z uporabo viskozimetra znamke Brookfield z vretenom št. 2, pri čemer je omenjeni film mogoče pridobiti s pripravo raztopine omenjenega sredstva za tvorjenje filma, pri čemer raztopina vsebuje tudi najmanj eno biološko aktivno snov in/ali najmanj eno terapevtsko aktivno snov, tako da se raztopino razporedi po trdni površini in omogoči, da se posuši na njej.
- 10. Metoda v skladu s patentnim zahtevkom 9, pri čemer je monovalentni kation izbran med Na+, K+ in NH4+.
- 11. Metoda v skladu s patentnim zahtevkom 9 ali 10, pri čemer alginatna sol monovalentnega kationa zajema od 25- do 35-odstotni masni delež β-D manuronata in/ali od 65- do 75-odstotni masni delež α-D guluronata.
- 12. Metoda v skladu s katerim koli patentnim zahtevkom 9-11, pri čemer je v raztopini prisoten plastifikator in/ali polnilo.
- 13. Metoda v skladu s katerim koli patentnim zahtevkom 9-12, pri čemer je najmanj ena biološko aktivna snov in/ali najmanj ena terapevtsko aktivna snov raztopljena ali suspendirana v omenjeni raztopini.
- 14. Metoda v skladu s katerim koli patentnim zahtevkom 9-13, ki zajema pripravo odmerkov filma.
- 15. Uporaba sestave za pripravo vodotopnega filma, pri čemer omenjena sestava zajema najmanj eno biološko aktivno snov in/ali najmanj eno terapevtsko aktivno snov ter sredstvo za tvorjenje filma, pri čemer je omenjeno sredstvo za tvorjenje filma sestavljeno iz alginatne soli monovalentnega kationa ali mešanice alginatnih soli monovalentnega kationa ter pri čemer ima omenjeno sredstvo za tvorjenje filma guluronat (G) s povprečno vsebnostjo od 50- do 85-odstotnega masnega deleža, manuronat (M) s povprečno vsebnostjo od 15- do 50-odstotnega masnega deleža in povprečno molekulsko maso od 30.000 g/mol do 90.000 g/mol, pri čemer ima njuna 10-odstotna vodna raztopina pri temperaturi 20 °C viskoznost 100-1000 mPas, izmerjeno pri strižni hitrosti 20 vrt./min z uporabo viskozimetra znamke Brookfield z vretenom št. 2, pri čemer je omenjeni film mogoče pridobiti s pripravo raztopine omenjenega sredstva za tvorjenje filma, pri čemer raztopina vsebuje tudi najmanj eno biološko aktivno snov in/ali najmanj eno terapevtsko aktivno snov, tako da se raztopino razporedi po trdni površini in omogoči, da se posuši na njej.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0502900A SE530184C2 (sv) | 2005-12-23 | 2005-12-23 | Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater |
PCT/SE2006/050626 WO2007073346A1 (en) | 2005-12-23 | 2006-12-22 | Water-soluble films comprising low-viscosity alginates |
EP06844046.0A EP1976562B1 (en) | 2005-12-23 | 2006-12-22 | Water-soluble films comprising low-viscosity alginates |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1976562T1 true SI1976562T1 (sl) | 2018-06-29 |
Family
ID=38188958
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200632248T SI1976562T1 (sl) | 2005-12-23 | 2006-12-22 | Vodotopni filmi, ki zajemajo alginate z nizko stopnjo viskoznosti |
Country Status (25)
Country | Link |
---|---|
US (1) | US8759282B2 (sl) |
EP (2) | EP3335732B1 (sl) |
JP (1) | JP5425471B2 (sl) |
KR (2) | KR20080080405A (sl) |
CN (1) | CN101346154B (sl) |
AU (1) | AU2006327277B2 (sl) |
BR (1) | BRPI0620403B8 (sl) |
CA (1) | CA2633878C (sl) |
CY (1) | CY1120100T1 (sl) |
DK (1) | DK1976562T3 (sl) |
ES (1) | ES2664975T3 (sl) |
HR (1) | HRP20180420T1 (sl) |
HU (1) | HUE038619T2 (sl) |
IL (1) | IL191994A (sl) |
LT (1) | LT1976562T (sl) |
NO (1) | NO343482B1 (sl) |
NZ (1) | NZ569261A (sl) |
PL (1) | PL1976562T3 (sl) |
PT (1) | PT1976562T (sl) |
RS (1) | RS57034B1 (sl) |
RU (1) | RU2445977C2 (sl) |
SE (1) | SE530184C2 (sl) |
SI (1) | SI1976562T1 (sl) |
WO (1) | WO2007073346A1 (sl) |
ZA (1) | ZA200805287B (sl) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL175338A0 (en) | 2006-05-01 | 2006-09-05 | Biota Ltd | Orally administrable films and preparation thereof |
DK2405942T3 (en) * | 2009-03-13 | 2018-02-05 | Excellent Tech Products I Sverige Ab | PRODUCT FOR ORAL SUBMISSION |
JP2012522765A (ja) * | 2009-04-03 | 2012-09-27 | エクス−インターナショナル・エピエス | 植物繊維製品およびその製造方法 |
KR101902039B1 (ko) * | 2011-04-08 | 2018-09-27 | 나노시타 가부시키가이샤 | 의약 제제 |
ITTO20120258A1 (it) * | 2012-03-21 | 2013-09-22 | Fond Istituto Italiano Di Tecnologia | Materiali compositi polimerici con proprieta' antimicrobiche e biodegradabili e loro usi. |
US10799451B2 (en) * | 2012-03-27 | 2020-10-13 | Nicoccino Ab | Nicotine formulation |
EP2830589B1 (en) * | 2012-03-27 | 2019-02-13 | Nicoccino Ab | Nicotine formulation |
RU2525926C1 (ru) * | 2013-01-09 | 2014-08-20 | Мария Александровна Никулина | Водорастворимая биодеградируемая съедобная упаковочная пленка |
JP6001108B2 (ja) * | 2015-02-02 | 2016-10-05 | エクス−インターナショナル・エピエス | 植物繊維製品およびその製造方法 |
CN110381921A (zh) * | 2016-11-15 | 2019-10-25 | 卡里亚制药控股有限公司 | 药物制剂 |
GB201709141D0 (en) * | 2017-06-08 | 2017-07-26 | Klaria Pharma Holding Ab | Pharmaceutical formulation |
JP2021506986A (ja) * | 2017-12-20 | 2021-02-22 | クラリア・ファルマ・ホールディング・アクチボラグ | バルデナフィルを含むフィルム配合物、その調製法、およびその使用 |
GB201807942D0 (en) * | 2018-05-16 | 2018-06-27 | Klaria Pharma Holding Ab | Pharmaceutical formulation |
GB201808462D0 (en) | 2018-05-23 | 2018-07-11 | Klaria Pharma Holding Ab | Pharmaceutical formulation |
CN108815141A (zh) * | 2018-08-24 | 2018-11-16 | 中国农业科学院饲料研究所 | 抗菌肽膜剂及其制备方法与应用 |
JP2022516404A (ja) * | 2018-12-28 | 2022-02-28 | フィリップ・モーリス・プロダクツ・ソシエテ・アノニム | 金属塩を含むニコチン製剤 |
US11877590B2 (en) | 2019-03-27 | 2024-01-23 | Fiedler & Lundgren Ab | Smokeless tobacco composition |
GB201911715D0 (en) * | 2019-08-15 | 2019-10-02 | Klaria Pharma Holding Ab | Film formulation comprising carriers |
WO2021090309A1 (en) | 2019-11-04 | 2021-05-14 | Maabarot Products Ltd. | Orally administrable films comprising poorly water soluble active ingredients and preparation thereof |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4031200A (en) * | 1975-12-15 | 1977-06-21 | Hoffmann-La Roche Inc. | Manufacture of pharmaceutical unit dosage forms |
US4029758A (en) * | 1975-12-15 | 1977-06-14 | Hoffmann-La Roche Inc. | Preparation of pharmaceutical unit dosage forms |
US4029757A (en) * | 1975-12-15 | 1977-06-14 | Hoffmann-La Roche Inc. | Manufacture of pharmaceutical unit dosage forms |
US4713239A (en) * | 1979-05-29 | 1987-12-15 | Vsesojuny Kardiologichesky Nauchny Tsentr Adkaemii Meditsinski Nauk Sssr | Antianginal film and method of treating ischemic heart disease |
GB8301659D0 (en) * | 1983-01-21 | 1983-02-23 | Leo Ab | Smoking substitutes |
US5783207A (en) * | 1985-05-01 | 1998-07-21 | University Of Utah Research Foundation | Selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine |
US5229164A (en) * | 1985-12-19 | 1993-07-20 | Capsoid Pharma Gmbh | Process for producing individually dosed administration forms |
JPH0729915B2 (ja) * | 1986-02-01 | 1995-04-05 | 帝國製薬株式会社 | シ−ト状口腔内貼付剤 |
US4867970A (en) * | 1987-05-21 | 1989-09-19 | E. R. Squibb & Sons, Inc. | Moistureless oral drug delivery formulation and method for preparing same |
US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US5446070A (en) * | 1991-02-27 | 1995-08-29 | Nover Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
US4900552A (en) * | 1988-03-30 | 1990-02-13 | Watson Laboratories, Inc. | Mucoadhesive buccal dosage forms |
US5047244A (en) * | 1988-06-03 | 1991-09-10 | Watson Laboratories, Inc. | Mucoadhesive carrier for delivery of therapeutical agent |
JPH02258718A (ja) * | 1989-03-31 | 1990-10-19 | Nippon Kayaku Co Ltd | ペースト状基剤及び製剤 |
IT1248666B (it) * | 1990-05-30 | 1995-01-26 | Fidia Spa | Gel in forma di film autosupportanti altamente idrati, processo per laloro preparazione e impiego nella terapia di lesioni e/o patologie cutanee |
GB9016056D0 (en) | 1990-07-21 | 1990-09-05 | Chatfield Pharmaceuticals Limi | Transdermal medicine delivery devices |
SE466134B (sv) * | 1990-11-22 | 1992-01-07 | Kabi Pharmacia Ab | Gelbildande flytande baerarkomposition samt anvaendning daerav i farmaceutiska kompositioner |
IT1250421B (it) * | 1991-05-30 | 1995-04-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive. |
US5215758A (en) * | 1991-09-11 | 1993-06-01 | Euroceltique, S.A. | Controlled release matrix suppository for pharmaceuticals |
US5192802A (en) * | 1991-09-25 | 1993-03-09 | Mcneil-Ppc, Inc. | Bioadhesive pharmaceutical carrier |
US5318780A (en) * | 1991-10-30 | 1994-06-07 | Mediventures Inc. | Medical uses of in situ formed gels |
US5346701A (en) * | 1993-02-22 | 1994-09-13 | Theratech, Inc. | Transmucosal delivery of macromolecular drugs |
CA2169729C (en) * | 1993-08-19 | 2001-04-03 | James E. Biegajski | Water-soluble pressure-sensitive mucoadhesive |
ATE246909T1 (de) * | 1994-03-07 | 2003-08-15 | Theratech Inc | Medikament enthaltende, adhesive, zusammenbaubare,transdermale abgabevorrichtung |
JPH09503023A (ja) * | 1994-06-16 | 1997-03-25 | フアルマシア・エツセ・ピー・アー | 生物付着性澱粉及び該澱粉の製造方法 |
AU2703795A (en) * | 1994-06-23 | 1996-01-19 | Procter & Gamble Company, The | Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine |
GB9504599D0 (en) * | 1995-03-03 | 1995-04-26 | Reckitt & Colmann Prod Ltd | Improvements in or relating to organic compositions |
GB2298365B (en) | 1995-03-03 | 1997-05-07 | Reckitt & Colmann Prod Ltd | A liquid pharmaceutical composition alginate and potassium bicarbonate |
DE19646392A1 (de) * | 1996-11-11 | 1998-05-14 | Lohmann Therapie Syst Lts | Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht |
NO983911D0 (no) | 1998-08-26 | 1998-08-26 | Norsk Hydro As | Alginatkapsler til bruk ved behandling av hjernesvulst |
GB0005743D0 (en) * | 2000-03-10 | 2000-05-03 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions including alginates |
US6932861B2 (en) | 2000-11-28 | 2005-08-23 | Fmc Corporation | Edible PGA coating composition |
US6419903B1 (en) | 2001-08-20 | 2002-07-16 | Colgate Palmolive Company | Breath freshening film |
DK1463491T3 (da) | 2001-10-12 | 2012-12-03 | Monosolrx Llc | Tynd film med ikke selvaggregerende ensartet heterogenitet, fremgangsmåde til fremstilling deraf og lægemiddelafgivelsessystemer fremstillet deraf |
CA2473970C (en) | 2001-10-12 | 2013-05-28 | Monosolrx Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
FR2832311B1 (fr) * | 2001-11-21 | 2004-04-16 | Besins Int Belgique | Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations |
GB2384986B (en) * | 2002-02-12 | 2004-01-07 | Reckitt Benckiser Healthcare | Compositions for the treatment of disorders of the upper gastrointestinal tract |
NO20021592D0 (no) | 2002-04-04 | 2002-04-04 | Fmc Biopolymer As | Polysakkaridkapsler og fremgangsmåte ved fremstilling derav |
GB0210216D0 (en) | 2002-05-03 | 2002-06-12 | First Water Ltd | Ionically crosslinked alginate hydrogels, process for their manufacture and their use in medical devices |
US20040131661A1 (en) * | 2002-07-26 | 2004-07-08 | Pfizer Inc. | Process for making orally consumable dosage forms |
GB0217382D0 (en) * | 2002-07-26 | 2002-09-04 | Pfizer Ltd | Process for making orally consumable dosage forms |
CA2504283A1 (en) | 2002-10-31 | 2004-05-21 | Umd, Inc. | Therapeutic compositions for drug delivery to and through covering epithelia |
US20040115137A1 (en) * | 2002-12-17 | 2004-06-17 | Verrall Andrew P. | Water-soluble film for oral administration |
CN100581586C (zh) | 2003-01-31 | 2010-01-20 | 奥雷克索公司 | 一种快速起效的药物组合物 |
GB2398496A (en) | 2003-02-20 | 2004-08-25 | Reckitt Benckiser Healthcare | Suspensions of water-swellable polymer particles which are substantially water-free or contain insufficient water to fully swell the particles |
US20050013847A1 (en) * | 2003-04-14 | 2005-01-20 | Fmc Corporation | Delivery systems of homogeneous, thermoreversible alginate films |
US7807194B2 (en) | 2003-04-14 | 2010-10-05 | Fmc Corporation | Homogeneous, thermoreversible gel film containing kappa-2 carrageenan and soft capsules made therefrom |
US20050019294A1 (en) * | 2003-04-14 | 2005-01-27 | Fmc Corporation | Homogeneous, thermoreversible alginate films and soft capsules made therefrom |
US7243881B2 (en) * | 2003-06-03 | 2007-07-17 | The Boeing Company | Multi-function trailing edge devices and associated methods |
ATE433746T1 (de) * | 2004-03-12 | 2009-07-15 | Biodel Inc | Insulinzusammensetzungen mit verbesserter wirkstoffabsorption |
-
2005
- 2005-12-23 SE SE0502900A patent/SE530184C2/sv unknown
-
2006
- 2006-12-22 CA CA2633878A patent/CA2633878C/en active Active
- 2006-12-22 CN CN2006800488663A patent/CN101346154B/zh active Active
- 2006-12-22 HU HUE06844046A patent/HUE038619T2/hu unknown
- 2006-12-22 EP EP18155276.1A patent/EP3335732B1/en active Active
- 2006-12-22 ZA ZA200805287A patent/ZA200805287B/xx unknown
- 2006-12-22 JP JP2008547188A patent/JP5425471B2/ja active Active
- 2006-12-22 PT PT68440460T patent/PT1976562T/pt unknown
- 2006-12-22 AU AU2006327277A patent/AU2006327277B2/en active Active
- 2006-12-22 KR KR1020087018096A patent/KR20080080405A/ko active Application Filing
- 2006-12-22 DK DK06844046.0T patent/DK1976562T3/en active
- 2006-12-22 LT LTEP06844046.0T patent/LT1976562T/lt unknown
- 2006-12-22 PL PL06844046T patent/PL1976562T3/pl unknown
- 2006-12-22 KR KR1020147008366A patent/KR101484530B1/ko active IP Right Grant
- 2006-12-22 ES ES06844046T patent/ES2664975T3/es active Active
- 2006-12-22 WO PCT/SE2006/050626 patent/WO2007073346A1/en active Application Filing
- 2006-12-22 RU RU2008130391/15A patent/RU2445977C2/ru not_active Application Discontinuation
- 2006-12-22 NZ NZ569261A patent/NZ569261A/xx unknown
- 2006-12-22 EP EP06844046.0A patent/EP1976562B1/en active Active
- 2006-12-22 US US12/158,472 patent/US8759282B2/en active Active
- 2006-12-22 SI SI200632248T patent/SI1976562T1/sl unknown
- 2006-12-22 RS RS20180290A patent/RS57034B1/sr unknown
- 2006-12-22 BR BRPI0620403A patent/BRPI0620403B8/pt active IP Right Grant
-
2008
- 2008-06-05 IL IL191994A patent/IL191994A/en active IP Right Grant
- 2008-07-22 NO NO20083226A patent/NO343482B1/no unknown
-
2018
- 2018-03-09 HR HRP20180420TT patent/HRP20180420T1/hr unknown
- 2018-03-27 CY CY20181100349T patent/CY1120100T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI1976562T1 (sl) | Vodotopni filmi, ki zajemajo alginate z nizko stopnjo viskoznosti | |
JP3977463B2 (ja) | 徐放性組成物 | |
HRP20180177T1 (hr) | Proizvod namijenjen oralnom unosu | |
BRPI0913204A2 (pt) | materiais de gesso | |
KR101233043B1 (ko) | 필름형 조성물 | |
JP2004503478A (ja) | 歯および/または骨組織の処置用組成物 | |
US4619701A (en) | Isolating agent | |
MY183216A (en) | Nicotine formulation | |
KR20150126613A (ko) | 코팅 조성물, 코팅 제제 및 그 제조 방법 | |
HRP20151421T1 (hr) | Postupak pripreme otopine levotiroksina | |
BR112015002270B1 (pt) | Pó de lactato e método para a preparação do mesmo | |
CN104371695A (zh) | 应用于页岩气工厂化压裂开采的滑溜水及其制备方法 | |
Wassel et al. | Ion release and enamel remineralizing potential of miswak, propolis and chitosan nano-particles based dental varnishes | |
KR20160081382A (ko) | 주입 성형이 가능한 겔화 지연형 하이드로겔 조성물 및 이의 제조방법 | |
PL195410B1 (pl) | Zastosowanie kompozycji farmaceutycznej zawierającej alginian sodu do wytwarzania leku | |
RU2676474C2 (ru) | Составы и способы, применяемые для удаления оболочек таблеток | |
JP6619933B2 (ja) | 帯電防止剤組成物 | |
HRP20190598T1 (hr) | Formulacija nikotina | |
KR101958158B1 (ko) | 이산화 탄소 외용제 조제용 조성물, 그 제조 방법, 이산화 탄소 외용제, 및 화장용 팩 | |
US3681489A (en) | Method of forming films | |
CN102432231B (zh) | 建筑用粉末胶粘剂 | |
ES2274990T3 (es) | Pelicula de superficie con funcion de deposito, su produccion y su uso. | |
KR101087354B1 (ko) | 구조화된 액체 세제 조성물 | |
WO2002074100A1 (fr) | Composition gel | |
RU2432333C1 (ru) | Добавка для замедления схватывания гипса |